Form 4 for DXCM Dexcom
Accepted 2025-11-10 00:00:00 ET · period of report 2025-11-10 · accession 0001093557-25-000283 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-11-10 | 2025-11-10 | DXCM | Collins Richard Alexander | Dir | S - Sale | $55.17 | -3,948 | 38.0K | -9% | -$217.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-10 | S | D | 3,948 | $55.17 | 37,994 | I by Trust | — | — | (F1) On August 7, 2025, the Richard A. Collins Revocable Trust (the "Trust") adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by the Trust. The shares set forth above were sold pursuant to the 10b5-1 Plan. (F2) Shares are held by the Richard A. Collins Revocable Trust, with respect to which the reporting person is a trustee. |